Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study)

Author： Milionis Haralampos J.   Rizos Evangelos   Kostapanos Michael   Filippatos Theodosios D.   Gazi Irene F.   Ganotakis Emmanuel S.   Goudevenos John   Mikhailidis Dimitri P.   Elisaf Moses S.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.22, Iss.6, 2006-06, pp. : 1123-1131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH)

By ter Avest Ewoud   Abbink Evertine J.   Holewijn Suzanne   de Graaf Jacqueline   Tack Cees J.   Stalenhoef Anton F. H.  

Current Medical Research and Opinion, Vol. 21, Iss. 9, 2005-09 ,pp. : 1469-1476

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Tolerability of Rosuvastatin and Atorvastatin when Force-Titrated in Patients with Primary Hypercholesterolemia

By  

Cardiology, Vol. 111, Iss. 4, 2008-04 ,pp. : 219-228

Karger

Access to resources Recommend Favorite

The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value – an Evaluation of Rosuvastatin therapY compared with atorvastatin

By Fonseca Francisco A. H.   Ruiz Alvaro   Cardona-Muñoz Ernesto G.   Silva Jose M.   Fuenmayor Nery   Marotti Marcelo  

Current Medical Research and Opinion, Vol. 21, Iss. 8, 2005-08 ,pp. : 1307-1316

Informa Healthcare

Access to resources Recommend Favorite

Achieving recommended low density lipoprotein cholesterol goals and the factors associated with target achievement of hypercholesterolemia patients with rosuvastatin in primary care

By Lee Jung Ah  

Current Medical Research and Opinion, Vol. 29, Iss. 7, 2013-07 ,pp. : 751-760

Informa Healthcare

Access to resources Recommend Favorite

Effect of fixed‐dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS‐ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 34, Iss. 5, 2016-10 ,pp. : 371-382

John Wiley & Sons Inc

Access to resources Recommend Favorite